Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Miliciclib
2. N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1h-pyrazolo(4,3-h)quinazoline-3-carboxamide
3. Pha 848125
4. Pha-848125
5. Pha-848125ac
6. Pha848125
1. Pha-848125
2. 802539-81-7
3. Pha 848125
4. Milciclib [inn]
5. Milciclib (pha-848125)
6. Pha848125
7. 4,5-dihydro-n,1,4,4-tetramethyl-8-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide
8. Mmv676602
9. N,1,4,4-tetramethyl-8-[4-(4-methylpiperazin-1-yl)anilino]-5h-pyrazolo[4,3-h]quinazoline-3-carboxamide
10. 688000m8s8
11. 1h-pyrazolo(4,3-h)quinazoline-3-carboxamide, 4,5-dihydro-n,1,4,4-tetramethyl-8-((4-(4-methyl-1-piperazinyl)phenyl)amino)-
12. N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide
13. N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1h-pyrazolo(4,3-h)quinazoline-3-carboxamide
14. N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide
15. Unii-688000m8s8
16. 4,5-dihydro-n,1,4,4-tetramethyl-8-((4-(4-methyl-1-piperazinyl)phenyl)amino)-1h-pyrazolo(4,3-h)quinazoline-3-carboxamide
17. Milciclib; Pha 848125
18. Mls006011032
19. Schembl619139
20. Chembl564829
21. Gtpl7938
22. Pha-848125 - Milciclib
23. Bdbm31545
24. Dtxsid80230186
25. Bcpp000109
26. Hms3656p21
27. Bcp01918
28. Ex-a2135
29. Nsc800792
30. S2751
31. Zinc53119602
32. Akos030231455
33. Ccg-269340
34. Cs-0579
35. Nsc-800792
36. Sb16657
37. Ncgc00346673-01
38. Ncgc00346673-05
39. Ac-35945
40. As-56203
41. Hy-10424
42. Smr004700646
43. Db-075668
44. Ft-0732566
45. Sw219949-1
46. D82291
47. Pyrazolo[4,3-h]quinazoline-3-carboxamide, 28
48. Sr-05000022565
49. J-523919
50. Sr-05000022565-1
51. Pha-848125,cas:802539-81-7
52. Q27086363
53. 8-[4-(4-methyl-piperazin-1-yl)-phenylamino]-1,4,4-trimethyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxylic Acid Methylamide
54. N,1,4,4-tetramethyl-8-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-5h-pyrazolo[4,5-h]quinazoline-3-carboxamide
| Molecular Weight | 460.6 g/mol |
|---|---|
| Molecular Formula | C25H32N8O |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 460.26990767 g/mol |
| Monoisotopic Mass | 460.26990767 g/mol |
| Topological Polar Surface Area | 91.2 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 718 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
16
PharmaCompass offers a list of Milciclib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Milciclib manufacturer or Milciclib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Milciclib manufacturer or Milciclib supplier.
PharmaCompass also assists you with knowing the Milciclib API Price utilized in the formulation of products. Milciclib API Price is not always fixed or binding as the Milciclib Price is obtained through a variety of data sources. The Milciclib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Milciclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milciclib, including repackagers and relabelers. The FDA regulates Milciclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milciclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Milciclib supplier is an individual or a company that provides Milciclib active pharmaceutical ingredient (API) or Milciclib finished formulations upon request. The Milciclib suppliers may include Milciclib API manufacturers, exporters, distributors and traders.
Milciclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milciclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milciclib GMP manufacturer or Milciclib GMP API supplier for your needs.
A Milciclib CoA (Certificate of Analysis) is a formal document that attests to Milciclib's compliance with Milciclib specifications and serves as a tool for batch-level quality control.
Milciclib CoA mostly includes findings from lab analyses of a specific batch. For each Milciclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milciclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Milciclib EP), Milciclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milciclib USP).
